1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsApplication opens June 11, 2026; deadline July 10, 2026 at 11:59 PM EST. This is the Summer 2026 cycle.
BioCAN Grants is sponsored by Heartland BioWorks. BioCAN Grants offset project costs for late-stage development, clinical, and commercialization activities that utilize Indiana's network of biotechnology drug substance manufacturers; industrial biotechnology precision fermentation manufacturers; formulation, fill, and finish dr…
Get alerted about grants like this
Save a search for “Heartland BioWorks” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
BioCAN Grants - Heartland BioWorks Accelerated biotech commercialization through funded access to Indiana's CDMO and scale-up infrastructure The BioLaunch project for the Heartland BioWorks Tech Hub aims to accelerate innovation, development, and commercialization of biotechnology and biomanufacturing solutions through two key programs: 1) BioStart provi des mentorship and peer-to-peer support for biotech startups, and 2) BioCAN (the BioResource Coordination and Access Network) connects biotech innovators with Indiana resources and provides grants to support scale-up and commercialization of solutions.
Indiana is home to a robust network of contract development & manufacturing organizations (CDMOs), labs, and digital assets equipped to accelerate commercialization of a wide range of biotechnology solutions.
Heartland BioWorks seeks to support innovator access to Indiana’s network of biotechnology drug substance manufacturers; industrial biotechnology precision fermentation manufacturers; formulation, fill, and finish drug product manufacturers (for both biopharmaceutical and pharmaceutical products); and other contract or support organizations relevant to biotech development.
BioCAN Grants will offset project costs for late-stage development, clinical, and commercialization activities that utilize these resources in Indiana. The U.S. Economic Development Administration (EDA) has approved deployment of $9,000,000 of non-dilutive fixed amount awards as BioCAN Grants over the next several years.
Individual grants will range from $50,000 to $500,000, with an expected total between $500,000 and $1,000,000 in awards per funding cycle. Please review program guidelines for detailed eligibility requirements and more information. Organizations (for-profit, non-profit, or academic institutions) with a registered legal entity in the United States, Organizations with an active registration in SAM.
gov and a Unique Entity Identifier (UEI) Organizations generally classified as small businesses (generally less than 1,000 employees; see program guidelines) Organizations developing and commercializing one of the following: biotechnology (human, animal, or plant) advanced biomanufacturing innovations (software, hardware or equipment, material science, process innovation, etc.) combination products (medical device combined with biotechnology) analytical tools associated with biomanufacturing or biotechnology development advanced manufacturing solutions associated with biomanufacturing Organizations utilizing Indiana-based CDMO, Laboratory, or other biotech resources (see list below for examples of Indiana-based companies supporting biotechnology innovations) Applicant organizations' solutions should be: at or beyond TRL 6 (Prototype System Verified), locked into a lead drug candidate, in late-stage preclinical development with final preparation of IND filing (human biotech), completing GLP (Good Laboratory Practice) testing completing engineering or GMP (Good Manufacturing Practice) manufacturing runs, initiating Phase 1 Clinical Trials, and/or demonstrating a prototype in the relevant environment.
Priority will be given to organizations: utilizing Indiana-based Contract Development and Manufacturing Organization (CDMO), Laboratory, or other biotech resources (see below for examples of Indiana-based resources) that have sufficient funding to sustain operations for at least the next 12 months Individual award amount: $50,000 to $500,000 Total amount per cycle: $500,000 to $1,000,000 Grants awarded per cycle: 2-4 grants Performance period: Up to 12 months Characteristics: Non-dilutive fixed amount award Please see guidelines linked below for eligible types of activities and more information Application opens: June 11, 2026 Application closes: July 10, 2026, 11:59pm EST (no extensions) Awardees notified: September 2026 Grant funds deployed: October-December 2026 Summer 2026 Program Guidelines Please review all program guidelines for eligible activities and more information.
Please populate the Excel budget template linked below and attach to your application. This is the only budget format that will be accepted. Meet some of Indiana's CDMO & lab resources Our network continues to grow, so check back soon as we add more resources to the list!
CDMO - Drug Product development & manufacturing: INCOG BioPharma Services - Fishers, IN KP Pharmaceutical Technology - Bloomington, IN Labyrinth BioPharma - Bloomington, IN MilliporeSigma - Indianapolis, IN Simtra BioPharma Solutions - Bloomington, IN Singota Solutions - Bloomington, IN CDMO - Gene & cell therapy Genezen - Indianapolis, IN CDMO - Precision fermentation & other EKF Diagnostics - South Bend, IN - precision fermentation, enzyme applications Evonik - Lafayette, IN - Lipid Innovation Center Liberation Bioindustries - Richmond, IN - precision fermentation (coming soon!)
MilliporeSigma - Indianapolis, IN - Lipid nanoparticle CDMO CDMO - Radiopharmaceuticals & nuclear medicine SpectronRx - Indianapolis and South Bend, IN Lab, Analytical, & Clinical Services B2S Life Sciences - Franklin, IN - Lab solutions, data analytics, drug development consulting Labcorp - Indianapolis, IN - Biopharma nonclinical development and central lab services Versiti Clinical Trial Services , including: Pearl Pathways - Clinical, regulatory, and quality compliance Quantigen - CRO, sample-to-answer method development and validation Cenetron - complete central laboratory services (Austin, TX) Please review our Program Guidelines (linked above).
If you still cannot find an answer to your question, please send an email to BioLaunch@theARI. us , and our team will respond within 1-3 business days. Authority: Applied Research Institute, Inc., 13598 E.
Westgate Dr., Odon, IN 47562 Project/Work: Heartland BioWorks: BioLaunch EDA Award Number: ED24HDQ0G0469 Heartland BioWorks is an ARI Pathfinder Network Community heartlandbioworks@theari. us Tags for Heartland BioWorks community. User Tags may not contain the following characters: @ # $ & :
According to the current listing, eligibility includes: U.S.-registered for-profit, non-profit, or academic organizations active on SAM.gov with a UEI; generally small businesses under ~1,000 employees; developing biotech, advanced biomanufacturing, drug delivery devices, combination products, or analytical/manufacturing tools at or beyond TRL 6. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000–$500,000 per grant. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for BioCAN Grants are due July 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
BioCAN Grants is funded by Heartland BioWorks. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Indiana. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.